Valeritas Holdings, Inc. is a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with diabetes. It offers products under the V-Go brand. V-Go Disposable Insulin Delivery Device, is used by patients with type 2 diabetes to maintain target blood glucose goals. The firm's single-use disposable V-Go device includes V-Go PreFill and V-Go Link. The company was founded by Leisa Swanson and Robert R. Gonnelli on May 9, 2014 and is headquartered in Bridgewater, NJ.
![Valeritas logo](/files/LOGO/1445274-VLRX.png)
Company profile
Website
CEO
John E. Timberlake
Employees
Incorporated
Location
Industry (SIC)
SEC CIK
Corporate docs
Latest filings (excl ownership)
RW
Registration withdrawal request
10 Mar 16
8-A12B
Registration of securities on exchange
17 Mar 15
S-1/A
IPO registration (amended)
9 Mar 15
S-1/A
IPO registration (amended)
24 Feb 15
S-1
IPO registration
12 Feb 15
DRS/A
Draft registration statement (amended)
24 Dec 14
DRS/A
Draft registration statement (amended)
21 Nov 14
DRS
Draft registration statement
8 Aug 14
D
$45M in equity, sold $21.95M, 26 investors
7 Jul 14
D
$150.61M in equity, sold $75.17M, 22 investors
20 Sep 11
Latest ownership filings